Brighton Jones LLC Amgen Inc Transaction History

Brighton Jones LLC

  • $2.55 Billion
  • Q3 2024

A detailed history of Brighton Jones LLC transactions in Amgen Inc stock. As of the latest transaction made, Brighton Jones LLC holds 22,242 shares of AMGN stock, worth $6.45 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
22,242
Previous 23,778 6.46%
Holding current value
$6.45 Million
Previous $7.43 Million 3.54%
% of portfolio
0.28%
Previous 0.25%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
SELL
$309.38 - $337.38 $475,207 - $518,215
-1,536 Reduced 6.46%
22,242 $7.17 Million
Q2 2024

Aug 12, 2024
SELL
$262.75 - $319.31 $65,687 - $79,827
-250 Reduced 1.04%
23,778 $7.43 Million
Q1 2024

May 09, 2024
BUY
$268.87 - $324.56 $148,416 - $179,157
552 Added 2.35%
24,028 $6.83 Million
Q4 2023

Feb 05, 2024
BUY
$255.7 - $288.46 $200,980 - $226,729
786 Added 3.46%
23,476 $6.76 Million
Q3 2023

Oct 25, 2023
BUY
$218.65 - $271.46 $208,154 - $258,429
952 Added 4.38%
22,690 $6.1 Million
Q2 2023

Jul 31, 2023
BUY
$214.27 - $253.37 $112,063 - $132,512
523 Added 2.47%
21,738 $4.83 Million
Q1 2023

May 08, 2023
BUY
$225.79 - $275.2 $68,640 - $83,660
304 Added 1.45%
21,215 $5.13 Million
Q4 2022

Feb 02, 2023
SELL
$229.03 - $291.01 $72,602 - $92,250
-317 Reduced 1.49%
20,911 $5.49 Million
Q3 2022

Nov 09, 2022
BUY
$224.46 - $253.15 $67,338 - $75,945
300 Added 1.43%
21,228 $4.79 Million
Q2 2022

Aug 04, 2022
SELL
$230.71 - $256.74 $77,749 - $86,521
-337 Reduced 1.58%
20,928 $5.09 Million
Q1 2022

May 13, 2022
SELL
$219.27 - $242.57 $112,704 - $124,680
-514 Reduced 2.36%
21,265 $5.14 Million
Q4 2021

Feb 03, 2022
BUY
$198.88 - $227.6 $21,280 - $24,353
107 Added 0.49%
21,779 $4.9 Million
Q3 2021

Nov 04, 2021
BUY
$212.27 - $248.7 $212 - $248
1 Added 0.0%
21,672 $4.61 Million
Q2 2021

Aug 10, 2021
BUY
$233.58 - $259.14 $34,336 - $38,093
147 Added 0.68%
21,671 $5.28 Million
Q1 2021

May 07, 2021
BUY
$221.91 - $258.6 $22,191 - $25,860
100 Added 0.47%
21,524 $5.36 Million
Q4 2020

Feb 10, 2021
BUY
$216.38 - $257.67 $2.3 Million - $2.74 Million
10,640 Added 98.66%
21,424 $4.93 Million
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $317,246 - $352,804
1,352 Added 14.33%
10,784 $2.74 Million
Q2 2020

Aug 11, 2020
SELL
$197.81 - $242.74 $1,384 - $1,699
-7 Reduced 0.07%
9,432 $2.23 Million
Q1 2020

May 13, 2020
BUY
$182.24 - $241.7 $25,878 - $34,321
142 Added 1.53%
9,439 $1.91 Million
Q4 2019

Feb 07, 2020
BUY
$189.21 - $243.2 $55,627 - $71,500
294 Added 3.27%
9,297 $2.24 Million
Q3 2019

Oct 28, 2019
SELL
$174.11 - $208.62 $148,167 - $177,535
-851 Reduced 8.64%
9,003 $1.74 Million
Q2 2019

Aug 05, 2019
SELL
$166.7 - $195.41 $15,503 - $18,173
-93 Reduced 0.93%
9,854 $1.82 Million
Q1 2019

Apr 26, 2019
BUY
$180.87 - $203.88 $9,224 - $10,397
51 Added 0.52%
9,947 $1.89 Million
Q4 2018

Feb 08, 2019
BUY
$178.4 - $208.25 $143,076 - $167,016
802 Added 8.82%
9,896 $1.93 Million
Q3 2018

Nov 07, 2018
BUY
$185.29 - $208.89 $1.2 Million - $1.35 Million
6,472 Added 246.83%
9,094 $1.89 Million
Q2 2018

Aug 06, 2018
BUY
$166.05 - $186.51 $17,933 - $20,143
108 Added 4.3%
2,622 $484,000
Q1 2018

May 03, 2018
SELL
$169.43 - $198.0 $63,875 - $74,646
-377 Reduced 13.04%
2,514 $429,000
Q4 2017

Feb 08, 2018
BUY
$168.79 - $188.59 $32,407 - $36,209
192 Added 7.11%
2,891 $503,000
Q3 2017

Nov 08, 2017
BUY
$167.29 - $191.0 $9,702 - $11,078
58 Added 2.2%
2,699 $503,000
Q2 2017

Aug 08, 2017
BUY
N/A
2,641
2,641 $455,000

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email